Most Read News

As per the company’s filing with the bourses, Biocon Biologics has developed and manufactured this injection while Yoshindo Inc.

The Board has proposed a final dividend of ₹6 per share and has also approved a new dividend policy of giving back up to 75% of free cash flow in the future.

Headline CPI drops. There’s more to the story as core CPI remains elevated. Will RBI continue its accommodative stance as widely expected?

The issue may be done through public offers or private placements. This subject to market conditions, and regulatory approvals, stated the public lender.

The contract is for executing KAVACH, an indigenous train collision avoidance system, in 778 route kilometers in the Bengaluru and Mysuru divisions.

Most of the IPO proceeds will be used for deleveraging, allowing for better margins and financial flexibility.

EBITDA increased 20.3% to ₹191.7 crore in the March 2025 quarter from ₹159.4 crore a year ago.

This latest order enlarges TCS’s continued engagement with BSNL to modernise the state-run telecom operator’s mobile infrastructure.

Bharat Elec is the only stock to hits 52-week high in Nifty

The company also said that its board has recommended a final dividend of ₹1.5 per equity share for the FY25.